IFLScience on MSN14h
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical Trials
A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Novel inhalable gene therapy trialed for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
The Scientist2y
A New Model of Lung Disease Paves the Way for Personalized Treatments
In a recent study published in the Journal of Cystic Fibrosis, Don Ingber and his group at the Wyss ... In 2010, his team created the first lung-on-a-chip, a small in vitro model that recreates the ...
Medical Xpress on MSN15d
Early immune system changes contribute to lung damage in cystic fibrosis
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Baylor College of Medicine4y
Cystic Fibrosis Center
The Baylor Medicine Maconda Brown O'Connor, Ph.D., Adult Cystic Fibrosis Center provides the highest quality care in a compassionate, patient-centered setting. Our center, which is accredited by the ...
USA Today11d
Everything to know about cystic fibrosis and what causes it
Cystic fibrosis (CF) is a progressive genetic disease that adversely affects a person's lungs, pancreas and other vital organs, says Dr. Michael Boyle, president and CEO of the Cystic Fibrosis ...
Kaleido Scope7y
Pulmonary Fibrosis and Interstitial Lung Disease
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Nature3y
Cystic fibrosis articles from across Nature Portfolio
Cystic fibrosis is a genetic disorder driven by CFTR ... intestines, and bronchi). Lung disease is responsible for the majority of morbidity in patients.
EurekAlert!2d
Novel inhalable gene therapy trialled for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.